ALT

Altimmune INC

+$1.4M

Net Activity

Institutions Holding

172

Popularity Rank

#3259

Avg Weight

0.01%

Total Value

$218.4M

Ownership Trend

172 institutions currently hold ALT, with 107 net buyers and 76 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

76

Net Buying Institutions

107

Key Holders

View all 172 holding institutions

Quarterly Activity

Recent Activity

+$153.6M

Total Buy Value

$79.2M

Total Sell Value

New buy25
Trim38
Add82
Sold out38

107

Net Buyers

76

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ALTIMMUNE INC (ALT)?
Major stakeholders currently include BlackRock, Inc. ($39.4M), State Street CORP ($22.0M), Vanguard Capital Management LLC ($17.4M). Based on the latest 13F filings, there are a total of 172 tracked investment funds and institutions maintaining positions in ALT.
What is the overall institutional sentiment toward ALT recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.4M, driven by 107 managers accumulating shares while 76 reduced their exposure.
Which institutions have been selling or reducing their ALT positions?
In the latest period, 38 funds trimmed their holdings, and 38 managers completely exited their positions. The aggregate reported sell value was $79.2M.
Are there any notable investors adding ALT to their portfolios?
Yes, buying activity remains notable. 25 institutions opened new positions in {ticker}, and 82 existing holders added to their shares. The total reported buy value for the quarter amounted to $153.6M.

Related Stocks